Cryolipolysis is a noninvasive cosmetic procedure that eliminates excess fat by freezing it. But a complication called paradoxical adipose hyperplasia (PAH) -a hardened area of localized fat developing after cryolipolysis ...
Jun 30, 2018
0
1
Pioneering research conducted by the University of Sheffield is paving the way for new treatments which could benefit patients suffering from the fatal lung disease pulmonary arterial hypertension (PAH).
Oct 15, 2012
0
0
Pulmonary arterial hypertension, a severe form of cardiopulmonary disease in which the arteries that transport blood from the heart to the lungs become thickened, constricted, and scarred, is a disease for which there is ...
Jun 13, 2018
0
39
High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs. A new study in The American Journal of Pathology sheds light ...
Dec 12, 2019
0
3
The deadly condition known as pulmonary arterial hypertension (PAH), which afflicts up to 150,000 Americans each year, may be reversible by using an inhalable gene therapy, report an international team of researchers led ...
Jul 30, 2013
0
0
(Medical Xpress)—The world's leading voices in the fight against pulmonary hypertension have compiled a special publication detailing the breakthrough research into the causes of this debilitating vascular disease.
Jan 6, 2014
0
0
Roofers and road construction workers who use hot asphalt are exposed to high levels of polycyclic aromatic hydrocarbons (PAHs). A University of Colorado Cancer Center study published this week in the British Medical Journal ...
Jul 26, 2012
0
0
Scientists at the Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health report the first evidence that prenatal exposure to polycyclic aromatic hydrocarbons (PAH)—carcinogenic ...
Oct 4, 2017
1
4
The largest study of genetic variation in patients with pulmonary arterial hypertension has associated two important genes with the disease.
Dec 6, 2018
0
4
The development of new, more effective vasodilators to treat pulmonary arterial hypertension (PAH) has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking ...
Jan 7, 2014
0
0
